---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-22-007812"
form_type: "8-K"
ticker: "AGPU"
cik: "0001446159"
company_name: "Axe Compute Inc."
filed_at: "2022-12-05T23:59:59+00:00"
generated_at: "2026-06-21T09:30:15.409696+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Predictive Oncology appoints Matthew J. Hawryluk, Ph.D. to Board of Directors

## Summary
- Appointed as Class II director effective Nov 29, 2022; fills vacancy from J. Melville Engle's retirement.
- Currently EVP and Chief Business Officer at Gritstone bio (NASDAQ: GRTS).
- Awarded $5,000 in common stock from the Company's 2012 Stock Incentive Plan.
- Bringing experience from Foundation Medicine and Thermo Fisher Scientific; Ph.D. in cell biology and MBA.
- His term expires at the 2023 annual meeting of stockholders.

## SEC filing metadata
- accession: 0001171843-22-007812
- form_type: 8-K
- ticker: AGPU
- cik: 0001446159
- company_name: Axe Compute Inc.
- filed_at: 2022-12-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1446159/000117184322007812/0001171843-22-007812-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1446159/000117184322007812/f8k_120222.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-22-007812
- JSON: https://secwatch.observer/filing/0001171843-22-007812.json
- Plain text: https://secwatch.observer/filing/0001171843-22-007812.txt

## Key facts
- Executive change
  Matthew J. Hawryluk, Ph.D. was elected as Class II director at Axe Compute Inc..
  - Action: elected
  - Role: Class II director
  source text: Effective November 29, 2022, the Board of Directors (“Board”) of Predictive Oncology Inc. (the “Company”) elected Matthew J. Hawryluk, Ph.D., to the Board as a Class II director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1446159/000117184322007812/0001171843-22-007812-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.